Works matching IS 14642662 AND DT 2010 AND VI 11 AND IP 2
Results: 12
Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Risk factors for and clinical characteristics of severe hyperlactataemia in patients receiving antiretroviral therapy: a case-control study.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment.
- Published in:
- HIV Medicine, 2010, v. 11, n. 2, p. 95, doi. 10.1111/j.1468-1293.2009.00747.x
- By:
- Publication type:
- Article
Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients.
- Published in:
- HIV Medicine, 2010, v. 11, n. 2, p. 104, doi. 10.1111/j.1468-1293.2009.00750.x
- By:
- Publication type:
- Article
Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study.
- Published in:
- HIV Medicine, 2010, v. 11, n. 2, p. 130, doi. 10.1111/j.1468-1293.2009.00751.x
- By:
- Publication type:
- Article
Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial.
- Published in:
- HIV Medicine, 2010, v. 11, n. 2, p. 137, doi. 10.1111/j.1468-1293.2009.00752.x
- By:
- Publication type:
- Article
Immunosuppression among HIV-1-positive patients attending for care: experience from two large HIV centres in the United Kingdom.
- Published in:
- HIV Medicine, 2010, v. 11, n. 2, p. 114, doi. 10.1111/j.1468-1293.2009.00753.x
- By:
- Publication type:
- Article
Risk factors for and clinical characteristics of severe hyperlactataemia in patients receiving antiretroviral therapy: a case–control study.
- Published in:
- HIV Medicine, 2010, v. 11, n. 2, p. 121, doi. 10.1111/j.1468-1293.2009.00754.x
- By:
- Publication type:
- Article
Discordant responses on starting highly active antiretroviral therapy: suboptimal CD4 increases despite early viral suppression in the UK Collaborative HIV Cohort (UK CHIC) Study.
- Published in:
- HIV Medicine, 2010, v. 11, n. 2, p. 152, doi. 10.1111/j.1468-1293.2009.00755.x
- By:
- Publication type:
- Article
Towards a combined prognostic index for survival in HIV infection: the role of ‘non-HIV’ biomarkers.
- Published in:
- HIV Medicine, 2010, v. 11, n. 2, p. 143, doi. 10.1111/j.1468-1293.2009.00757.x
- By:
- Publication type:
- Article